Glaxosmithkline Pharmaceuticals informs about analyst meet

18 Sep 2020 Evaluate
Pursuant to Regulation 30(6) of the Schedule Ill, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed about the details of Analyst or Institutional Meetings with the Company scheduled on 28th September 2020.
The above information is a part of company’s filings submitted to BSE.


Glaxosmithkline Phar Share Price

1859.90 -29.30 (-1.55%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.